Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Novocure stock
Learn how to easily invest in Novocure stock.
Novocure is a medical instruments & supplies business based in the US. Novocure shares (NVCR) are listed on the NASDAQ and all prices are listed in US Dollars. Novocure employs 1,167 staff and has a trailing 12-month revenue of around $542.6 million.
How to buy Novocure stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – NVCR. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Novocure stock price (NASDAQ: NVCR)Use our graph to track the performance of NVCR stocks over time.
Novocure shares at a glance
|Latest market close||$90.90|
|52-week range||$56.39 - $120.03|
|50-day moving average||$80.87|
|200-day moving average||$77.14|
|Wall St. target price||$104.43|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.57|
Buy Novocure stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Novocure stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Novocure price performance over time
|1 week (2023-01-20)||2.72%|
|1 month (2022-12-27)||32.01%|
|3 months (2022-10-31)||28.64%|
|6 months (2022-07-28)||29.41%|
|1 year (2022-01-31)||32.41%|
|2 years (2021-01-29)||-43.53%|
|3 years (2020-01-31)||11.59%|
|5 years (2018-01-30)||299.56%|
|Revenue TTM||$542.6 million|
|Gross profit TTM||$420.8 million|
|Return on assets TTM||-3.78%|
|Return on equity TTM||-19.03%|
|Market capitalisation||$9.1 billion|
TTM: trailing 12 months
Novocure share dividends
We're not expecting Novocure to pay a dividend over the next 12 months.
Novocure share price volatility
Over the last 12 months, Novocure's shares have ranged in value from as little as $56.39 up to $120.03. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Novocure's is 0.7656. This would suggest that Novocure's shares are less volatile than average (for this exchange).
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey. .
Novocure in the news
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Why Novocure Stock Is Sliding Today
Frequently asked questionsWhat percentage of Novocure is owned by insiders or institutions?
Currently 1.108% of Novocure shares are held by insiders and 80.843% by institutions. How many people work for Novocure?
Latest data suggests 1,167 work at Novocure. When does the fiscal year end for Novocure?
Novocure's fiscal year ends in December. Where is Novocure based?
Novocure's address is: No. 4 The Forum, Saint Helier, Jersey, JE2 4UF What is Novocure's ISIN number?
Novocure's international securities identification number is: JE00BYSS4X48 What is Novocure's CUSIP number?
Novocure's Committee on Uniform Securities Identification Procedures number is: G6674U108
More guides on Finder
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert